CD86 and neoplasm: Herein, bioinformatics analysis found that the expression levels of PD-L1, CD86, and CD206 were downregulated in tumor tissues, while immunohistochemical staining data showed that PD-L1, CD86, and CD206 were overexpressed in tumor tissues.